Influence of renal sympathetic denervation on quality of life

Journal of Interventional Cardiology

Volumn 26, Issue 5, 2013, Pages 536-541

  Dörr, Oliver ^a   Liebetrau, Christoph ^b   Möllmann, Helge ^b   Rixe, Johannes ^a   Hecker, Franziska ^a   Szardien, Sebastian ^b   Willmer, Matthias ^b   Hamm, Christian ^a   Nef, Holger M ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Kerckhoff Heart and Thorax Center ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANXIETY; ARTICLE; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; EMOTION; ENERGY; FEMALE; FOLLOW UP; HUMAN; KIDNEY DENERVATION; MALAISE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL SYMPATHETIC DENERVATION; RESISTANT HYPERTENSION; SHORT FORM 36; SYSTOLIC BLOOD PRESSURE; TELEPHONE INTERVIEW; TREATMENT RESPONSE;

FEMALE; HUMANS; HYPERTENSION, RENAL; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; QUALITY OF LIFE; RENAL ARTERY; SYMPATHECTOMY;

EID: 84885405633     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/joic.12057     Document Type: Article

References (17)

1. Hollenberg NK, Williams GH, Anderson R., Medical therapy, symptoms, and the distress they cause. Arch Intern Med 2000; 160: 1477-1483.
2. Anderson RT, Hogan P, Apel L, et al. Baseline correlates with quality of life among men and women with medication-controlled hypertension. The trial of nonpharmacologic interventions in the elderly (TONE). J Am Geriatr Soc 1997; 45: 1080-1085.
3. Bulpitt CJ, Dollery CT, Carne S., Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976; 38: 121-128.
4. Weiss NS., Relation of high blood pressure to headache, epistaxis, and selected other symptoms. The United States health examination survey of adults. N Engl J Med 1972; 287: 632-633.
5. Bansal S., Sexual dysfunction in hypertensive men: A critical review of the literature. Hypertension 1988; 12: 1-10.
6. Shapiro AP, Miller RE, King HE, et al. Behavioral consequences of mild hypertension. Hypertension 1982; 4: 355-360.
7. Vanderploeg RD, Goldman H, Kleinman KM., Relationship between systolic and diastolic blood pressure and cognitive functioning in hypertensive subjects: An extension of previous findings. Arch Clin Neuropsychol 1987; 2: 101-109.
8. Handler J., Quality of life and antihypertensive drug therapy. J Clin Hypertens 2005; 7: 274-285.
9. Cote I, Grégoire JP, Moisan J, et al. Quality for life in hypertension: The SF-12 compared to the SF-36. Can J Clin Pharmacol 2004; 1: 232-238.
10. Trevisol DJ, Moreira LB, Fuchs FD, et al. Health-related quality of life is worse in individuals with hypertension under drug treatment: Results of population-based study. J Hum Hypertens 2012; 26: 374-380.
11. Alonso J, Ferrer M, Gandek B, et al. Health related quality of life associated with chronic conditions in eight countries: results from the international Quality of Life Assessment (IQOLA) Profect. Qual Life Res 2004; 13: 283-298.
12. Barger SD, Muldoon MF., Hypertension labelling was associated with poorer self-rated health in the third US National Health and Nutrition Examination Survey 1. J Hum Hypertens 2006; 20: 117-123.
13. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-1281.
14. Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F, et al. Health-related quality of life of subjects with known and unknown hypertension: Results from the population-based Hortega study. J Hypertens 2003; 21: 1283-1289.
15. Centers for Disease Control & Prevention. Self-rated fair or poor health among adults with diabetes: United States, 1996-2005. Morb Mortal Wkly Rep 2006; 55: 1224-1227.
16. Lambert GW, Hering D, Esler MD, et al. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension 2012; 60: 1479-1484.
17. Erickson SR, Pharm D, Williams BC, et al. Relationship between symptoms and health-related quality of life in patients treated for hypertension. Pharmacotherapy 2004; 24: 344-350.